article Open AccessTop 1% cited
Methotrexate Pharmacokinetics
Journal of Pharmaceutical Sciences · 1971 · Vol. 60(8) · pp. 1128–1133
Kenneth B. Bischoff✉(National Institutes of Health)Robert L. Dedrick(United States Public Health Service)Daniel S. Zaharko(Cornell University)James Longstreth(Cornell University)
Acute Lymphoblastic Leukemia researchChemotherapy-induced organ toxicity mitigationBiochemical and Molecular ResearchPharmacokineticsMethotrexateDistribution (mathematics)PharmacologyGastrointestinal tractDihydrofolate reductaseDrugChemistryBiologyMedicine
MeSH terms
KineticsAdministration, OralAnimalsBody WeightDogsHumansInjections, IntravenousIntestinal AbsorptionKidneyLiverMethotrexateModels, BiologicalMusclesTime FactorsMice
Citations
477
FWCI
23.14
field-weighted impact
References
14
Percentile
100%
vs. same field & year
Citations per year
Cited by
Physiologically Based Pharmacokinetic Modeling: Principles and Applications
Journal of Pharmaceutical Sciences · 1983 · 574 citations
A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans
Toxicology and Applied Pharmacology · 1984 · 675 citations
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
European Journal of Medicinal Chemistry · 2018 · 541 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.